Anzeige
Mehr »
Login
Samstag, 27.07.2024 Börsentäglich über 12.000 News von 684 internationalen Medien
OMEGA Short Squeeze im Gange. MAJOR Hochgradige Entdeckung - 44,32m @ 3,16 g/t GOLD
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 873532 | ISIN: FR0000061129 | Ticker-Symbol: BON
Stuttgart
26.07.24
15:08 Uhr
31,800 Euro
0,000
0,00 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
BOIRON SA Chart 1 Jahr
5-Tage-Chart
BOIRON SA 5-Tage-Chart
RealtimeGeldBriefZeit
32,05032,80013:04
Actusnews Wire
211 Leser
Artikel bewerten:
(1)

BOIRON: EVOLUTION OF GOVERNANCE

July 3rd, 2024

The Board of Directors of Laboratoires BOIRON, meeting today under the chairmanship of Thierry BOIRON, has enacted an evolution of the Group's governance.

In this context, Thierry BOIRON has been appointed CEO, replacing Valérie LORENTZ-POINSOT, who simultaneously resigns from her position as Director of the board.

Anabelle FLORY-BOIRON, who worked for 19 years at Laboratoires BOIRON until December 2021 and has been a Director of BOIRON SA since 2020, has been appointed Chairman of the Board of Directors, replacing Thierry BOIRON.

Thierry BOIRON stated: "First of all, I would like to thank Valérie LORENTZ-POINSOT for her tireless efforts over more than 5 years as CEO in a particularly adverse environment. Her experience at the head of the group has enabled us to face various crises in recent years and initiate a new development strategy.

Today, I take over as CEO to lead a new cycle of ambitious and risky development.

My personal commitment to the role of CEO is accompanied by Anabelle FLORY-BOIRON's commitment as Chairman of BOIRON SA, Stéphanie CHESNOT-BOIRON as Chairman of SODEVA, and Laurence BOIRON as Chairman of SHB, the two family holdings."

Anabelle FLORY-BOIRON added: "I am very happy to succeed Thierry as Chairman of BOIRON and to continue the legacy of the third generation leading our family business."

We continue to put all our energy and determination into ensuring that every patient worldwide can benefit from homeopathy and our other health solutions, contributing to the development of a more humane, efficient, and sustainable healthcare system.

Laboratoires BOIRON

Press contact :

laura.maucci-ponzio@boiron.fr



Next press release: September 19, 2024, publication of the 2024 half-year results after the stock market closes.

Person responsible for financial information: Thierry Boiron

Contact for financial information: Fabrice Rey

Investor Relations: +33 (0) 4.37.41.84.01 - e-mail: boironfinances@boiron.fr

Code ISIN: FR0000061129 (BOI) - Bloomberg: BOI FP - Reuters: BOIR.PA

The group's financial information and the glossary are online at: www.boironfinance.com

------------------------
This publication embed "Actusnews SECURITY MASTER".
- SECURITY MASTER Key: nWueksqXYZmWyJpwksubaZZjaphllWGaZpXGm5KbZ5fHbpuWnWqVm8aWZnFnm2ht
- Check this key: https://www.security-master-key.com.
------------------------
Full and original release in PDF format:
https://www.actusnews.com/documents_communiques/ACTUS-0-86637-boi-030724-evolution-gouvernance-gb.pdf

© Copyright Actusnews Wire
Receive by email the next press releases of the company by registering on www.actusnews.com, it's free
© 2024 Actusnews Wire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.